Xuping Xi

745 total citations
9 papers, 96 citations indexed

About

Xuping Xi is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Xuping Xi has authored 9 papers receiving a total of 96 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Otorhinolaryngology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in Xuping Xi's work include Head and Neck Cancer Studies (5 papers), Lung Cancer Research Studies (3 papers) and Lung Cancer Treatments and Mutations (2 papers). Xuping Xi is often cited by papers focused on Head and Neck Cancer Studies (5 papers), Lung Cancer Research Studies (3 papers) and Lung Cancer Treatments and Mutations (2 papers). Xuping Xi collaborates with scholars based in China and United States. Xuping Xi's co-authors include Hui Wang, Hekun Jin, Jun Hu, Jumei Zhou, Xiaoxue Xie, Yun Li, Lin Zhang, Ling Yang, Feng Liu and Yaqian Han and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Xuping Xi

7 papers receiving 95 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xuping Xi China	5	59	37	30	26	19	9	96
Crosby D. Rock United States	6	49 0.8×	38 1.0×	43 1.4×	45 1.7×	25 1.3×	11	145
Matthew Griffin United Kingdom	3	36 0.6×	48 1.3×	29 1.0×	30 1.2×	65 3.4×	4	125
Shaoqiang Liang China	5	73 1.2×	31 0.8×	35 1.2×	20 0.8×	15 0.8×	10	111
Wei-Han Hu China	4	85 1.4×	46 1.2×	53 1.8×	14 0.5×	7 0.4×	6	118
Kwok Hung Au China	4	43 0.7×	46 1.2×	45 1.5×	12 0.5×	11 0.6×	7	87
C. Rossetto Italy	6	78 1.3×	72 1.9×	70 2.3×	30 1.2×	7 0.4×	16	136
Joseph Califano United States	2	52 0.9×	23 0.6×	27 0.9×	7 0.3×	40 2.1×	2	91
Michaela K. Keck United States	6	59 1.0×	43 1.2×	54 1.8×	32 1.2×	4 0.2×	13	106
Xinglai Feng China	7	54 0.9×	20 0.5×	59 2.0×	8 0.3×	7 0.4×	12	102
Rex H. Lee United States	6	26 0.4×	24 0.6×	55 1.8×	19 0.7×	7 0.4×	10	108

Countries citing papers authored by Xuping Xi

Since Specialization

Citations

This map shows the geographic impact of Xuping Xi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuping Xi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuping Xi more than expected).

Fields of papers citing papers by Xuping Xi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuping Xi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuping Xi. The network helps show where Xuping Xi may publish in the future.

Co-authorship network of co-authors of Xuping Xi

This figure shows the co-authorship network connecting the top 25 collaborators of Xuping Xi. A scholar is included among the top collaborators of Xuping Xi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuping Xi. Xuping Xi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Hong, Shaodong, Yan Huang, Yunpeng Yang, et al.. (2020). GEM20110714: Final overall survival results of the phase III study of first-line gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma.. Journal of Clinical Oncology. 38(15_suppl). 6521–6521. 3 indexed citations

Zheng, Baomin, Xiaodong Zhu, Mengzhong Liu, et al.. (2017). Randomized, Double-Blind, Placebo-Controlled Trial of Shuanghua Baihe Tablets to Prevent Oral Mucositis in Patients With Nasopharyngeal Cancer Undergoing Chemoradiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 100(2). 418–426. 24 indexed citations

Liu, Feng, Xuping Xi, Hui Wang, et al.. (2017). PET/CT-guided dose-painting versus CT-based intensity modulated radiation therapy in locoregional advanced nasopharyngeal carcinoma. Radiation Oncology. 12(1). 15–15. 28 indexed citations

Pol, Hilleke E. Hulshoff, et al.. (2017). Correlation of quantitative parameters of magnetic resonance perfusion‐weighted imaging with vascular endothelial growth factor, microvessel density and hypoxia‐inducible factor‐1α in nasopharyngeal carcinoma: Evaluation on radiosensitivity study. Clinical Otolaryngology. 43(2). 425–433. 11 indexed citations

Xi, Xuping, et al.. (2016). [Correlation between red cell distribution width and the severity and prognosis of chronic thromboembolic pulmonary hypertension].. PubMed. 39(6). 459–63. 1 indexed citations

Zhang, Li, Gengsheng Yu, Jun Jia, et al.. (2016). Gemcitabine plus cisplatin (GP) versus 5-FU plus cisplatin (FP) as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (NPC): A randomized, open-label, multicenter, phase III trial.. Journal of Clinical Oncology. 34(15_suppl). 6007–6007.

Jin, Hekun, Xiaoxue Xie, Hui Wang, et al.. (2014). ERCC1 Cys8092Ala and XRCC1 Arg399Gln Polymorphisms Predict Progression-Free Survival after Curative Radiotherapy for Nasopharyngeal Carcinoma. PLoS ONE. 9(7). e101256–e101256. 19 indexed citations

Xie, Xiaoxue, Hui Wang, Hekun Jin, et al.. (2013). Expression of pAkt affects p53 codon 72 polymorphism-based prediction of response to radiotherapy in nasopharyngeal carcinoma. Radiation Oncology. 8(1). 117–117. 10 indexed citations

Xi, Xuping. (2010). Issues on Target Delineation for Radiation with PET/CT.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact